Moneycontrol
Get App
Last Updated : May 03, 2017 02:17 PM IST | Source: CNBC-TV18

SeQuent's Vizag plant gets EIR from USFDA

SeQuent Scientific has received an establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA) for their animal active pharmaceutical ingredient (API) manufacturing plant at Visakhapatnam. In an interview to CNBC-TV18, Manish Gupta, CEO of the company spoke about the latest happenings in his company and sector.

SeQuent Scientific has received an establishment inspection report (EIR) from the United States Food and Drug Administration (USFDA) for their animal active pharmaceutical ingredient (API) manufacturing plant at Visakhapatnam.

In an interview to CNBC-TV18, Manish Gupta, CEO of the company spoke about the latest happenings in his company and sector.

The company has invested close to USD 40 million in its animal health arm Alivira. This plant was inspected in November 2016 by USFDA.

Close

EIR allows the company to sell its products in US markets.

US market is the largest veterinary market, which accounts for close to 40 percent of global veterinary market.

For more, watch video...

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on May 3, 2017 01:41 pm
Sections
Follow us on